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Abstract 1 
Inhalation of nanoparticles for pulmonary drug delivery offers the potential to harness nanomedicine 2 
formulations of emerging therapeutics, such as curcumin, for treatment of lung cancer. Biocompatible 3 
nanoparticles composed of poly(2-methacryloyloxyethyl phosphorylcholine)-b-poly(2-(diisopropylamino)ethyl 4 
methacrylate) (MPC-DPA) have been shown to be suitable nanocarriers for drugs, whilst N-trimethyl chitosan 5 
chloride (TMC) coating of nanoparticles has been reported to further enhance their cellular delivery efficacy; the 6 
combination of the two has not been previously investigated. Development of effective systems requires the 7 
predictable, controllable, and reproducible ability to prepare nanosystems possessing particle sizes, and drug 8 
loading capacities, appropriate for successful airway travel, lung tissue penetration, and tumour suppression.  9 
Although a number of MPC-DPA based nanosystems have been described, a complete understanding of 10 
parameters controlling nanoparticle formation, size, and morphology has not been reported; in particular the 11 
effects of differing solvents phases remains unclear. In this current study a matrix of 31 solvent combinations 12 
were examined to provide novel data pertaining to the formation of MPC-DPA nanoparticles, and in doing so 13 
afforded the selection of systems with particle sizes appropriate for pulmonary delivery applications to be loaded 14 
with curcumin, and coated with TMC. This paper presents the first report of novel data detailing the successful 15 
preparation, characterisation, and optimisation of MPC-DPA nanoparticles of circa 150 – 180 nm diameter, with 16 
low polydispersity, and a curcumin loading range of circa 2.5 – 115 µM, tunable by preparation parameters, with 17 
and without TMC coating, and thus considered suitable candidates for inhalation drug delivery applications. 18 
 19 
Keywords: 20 
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 22 
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1. Introduction 1 
The pulmonary route for therapeutic administration, via inhalation, is a well-suited and effective way to deliver 2 
therapeutic forms of hormones, peptides, and other drug molecules which are not easily absorbed through the 3 
gastrointestinal tract, into systemic circulation (Barnett, 2004; Kuzmov and Minko, 2015; Mack, 2007). 4 
Additionally, recent studies have highlighted that pulmonary delivery can be an effective method for the 5 
treatment of lung cancer, compared to the limitations associated with of conventional treatments such as chemo 6 
and radio therapy (Minko et al., 2013). 7 
The phosphorylcholine (PC) containing copolymer poly(2-methacryloyloxyethyl phosphorylcholine)-b-poly(2-8 
(diisopropylamino)ethyl methacrylate) (MPC-DPA) has well proven biocompatibility (Giacomelli et al., 2006; 9 
Porto et al., 2011; Yallapu et al., 2010; Yoshikawa et al., 2011), and self-assembles to form a range of 10 
nanostructures, including micelles, polymersomes, and higher-order assemblies when the DPA block is 11 
deprotonated at physiological pH 7.4. (Blanazs et al., 2009; Derry et al., 2016; Du et al., 2005; Pearson et al., 12 
2013; Porto et al., 2011; Robertson et al., 2014).  Moreover, when subsequently exposed to an acidic 13 
environment, for example tumor tissue, the DPA becomes protonated and hydrophilic, and the nanoparticles 14 
disassemble releasing the therapeutic payload (Pearson et al., 2013; Pegoraro et al., 2013; Salvage et al., 2005). 15 
Previous studies have highlighted that MPC-DPA diblock copolymers have the potential to be applied to a range 16 
of nanoparticle based clinical therapies, which can utilise the stable nanoparticles for drug delivery and cell 17 
targeting of hydrophobic and hydrophilic molecules, proteins, antibodies, and also genetic material (Canton et 18 
al., 2013; Colley et al., 2014; Licciardi et al., 2008, 2006, 2005, Lomas et al., 2010, 2008, 2007, Mu et al., 2008; 19 
Pegoraro et al., 2014, 2013; Salvage et al., 2005, 2015, 2016). However, copolymer size, the molecular weight 20 
(Mw), can affect membrane properties of the nano-assemblies, including thickness, rigidity, stability, and the 21 
mechanical properties of the resultant morphology formed (Ahmed et al., 2006; Discher et al., 2007; Discher and 22 
Ahmed, 2006; Motornov et al., 2010). Additionally, the stability and morphology of MPC-DPA nanoparticles 23 
depends on several key factors including the formation process, copolymer concentration, and the solvents used 24 
during assembly (Pearson et al., 2013; Pegoraro et al., 2014; Salvage et al., 2015). The predominant processes 25 
reported for the formation of MPC-DPA nanoparticles have been nanoprecipitation (Salvage et al., 2015, 2016) 26 
and film rehydration (Canton et al., 2013; Colley et al., 2014; Robertson et al., 2014), both of which use solvents 27 
within the process. However, there appears to be no single solvent combination suitable to dissolve the different 28 
block length copolymers at the same concentration (Ye et al., 2015). It has also been reported previously that 29 
MPC-DPA copolymers are selectively soluble in some organic solvents (Edmondson et al., 2010; Licciardi et al., 30 
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2005; Porto et al., 2011), and that choice of solvent can influence the resultant self-assembled nanoparticle size 1 
and polydispersity (Alexandridis and Spontak, 1999; Israelachvili, 2011; Meyer et al., 2006; Salvage et al., 2 
2015); however, to date, there has been no detailed and focused study of this effect 3 
Curcumin is an active pharmaceutical ingredient (API) which has demonstrated anti-cancer effects against lung, 4 
ovarian, pancreatic and colorectal cancers (Gou et al., 2011; Mock et al., 2015; Patil et al., 2015). However, the 5 
therapeutic advantages are often attenuated after oral administration due to the physicochemical properties of 6 
curcumin, such as low water solubility, < 1µg/mL, and a rapid half-life, with poor systemic bioavailability of < 1 7 
%. (Betbeder et al., 2015; Nahar et al., 2015; Patil et al., 2015; Shanmugam et al., 2015; Tomren et al., 2007; Xie 8 
et al., 2011; Zhang et al., 2013). To overcome these limitation, a number of approaches have been investigated 9 
previously, such as solid dispersions (Paradkar et al., 2004), liposomes (Saengkrit et al., 2014), and polymeric 10 
micro and nanoparticles (Kakran et al., 2012; Zhang et al., 2013), although none of these approaches yielded 11 
significant improvements in bioavilability. 12 
N-trimethyl chitosan chloride (TMC), like chitosan, has mucoadhesive properties which can help increase the 13 
transit time of drug nano-carriers into the gastrointestinal tract (GIT) and the absorption rate of drugs (Amidi et 14 
al., 2006; Zhang et al., 2013). Additionally, TMC can increase paracellular diffusion of nanoparticles, and drugs 15 
including curcumin, via epithelial cells by opening the tight junctions of the cell membrane (Amidi et al., 2006; 16 
El-Sherbiny and El-Baz, 2015; Guan et al., 2012; Sahni et al., 2008; Steed et al., 2010; Zhang et al., 2013). 17 
Compared to chitosan, TMC is more soluble in aqueous solutions, especially at neutral physiological pH 7.4 18 
(Sahni et al., 2008). It also has the ability to improve formulation stability and bioavailability, the stability of 19 
liposomes after coating, and is an effective enhancer of hydrophilic drug and protein absorption (Chen et al., 20 
2016; Panya et al., 2010). Moreover, TMC has displayed strong electrostatic interactions between polymer 21 
cationic amine groups and negatively charged tumor cells, thus providing targeted drug delivery properties 22 
(Guan et al., 2012; Thanou et al., 2000). Indeed, TMC has been shown to have many promising micro and 23 
nanoparticle based applications for oral, nasal, pulmonary, ocular, and intestinal delivery of drugs (Amidi et al., 24 
2006; El-Sherbiny and El-Baz, 2015; Guan et al., 2012; Sahni et al., 2008). Thus TMC coating of MPC-DPA 25 
nanoparticles may enhance their efficacy further, and contribute towards developing curcumin formulations with 26 
potential clinical applications for pulmonary delivered treatment of human lung cancers (Basnet and Skalko-27 
Basnet, 2011; Gou et al., 2011; Kakran et al., 2012; Mock et al., 2015; Nahar et al., 2015; Patil et al., 2015; 28 
Prasad et al., 2014; Saengkrit et al., 2014; Wang et al., 2015).  29 
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The study reported herein investigated the development of MPC-DPA nanoparticles as potential pulmonary drug 1 
delivery vehicles, based on controlling particle size such that effective airway travel and lung tissue penetration 2 
would theoretically be achievable. Preparation and characterisation was undertaken using two contrasting 3 
nanoparticle formation methods, nanoprecipitation and film rehydration, and the effects of 31 solvent mixes on 4 
nanoparticle size and polydispersity studied. After this initial screening, nanoparticle formulations possessing 5 
particle size and polydispersity values reported as suitable for pulmonary route applications, were selected for 6 
subsequent curcumin drug loading, which has promising anticancer effects, and TMC surface modification, 7 
which has tissue penetration enhancing properties. In summary, this paper details for the first time novel data 8 
pertaining to the development of curcumin loaded, and TMC modified, MPC-DPA nanoparticle formulations for 9 
inhalation based lung cancer therapies, and has also provided an extensive matrix of novel particle size 10 
controllability data that will be of value for development of further novel MPC-DPA nanoparticle based 11 
pharmaceutical delivery applications.  12 
 13 
2. Methods and materials 14 
2.1. Materials 15 
The MPC30-DPA100 and MPC100-DPA100 block copolymers were supplied by Prof Steven Armes (University of 16 
Sheffield, UK) having been synthesised by atom transfer radical polymerisation (ATRP), as detailed previously 17 
(Ma et al., 2003; Salvage et al., 2005). Methanol, ethanol, chloroform, isopropanol, acetonitrile, phosphate 18 
buffered saline, phosphotungstic acid, hydrochloric acid, sodium hydroxide, sodium chloride, deuterium oxide, 19 
curcumin 98%, methyl iodide 99%, sodium iodide 99%, 1-methyl-2-pyrrolidone 99.5%, 2 mL glass vials, 20 mL 20 
glass vials, 13 mm diameter glass cover slips, 2 mL plastic syringes, 0.45 µm and 0.22 µm syringe filters, were 21 
purchased from Fisher Scientific, UK. Transmission electron microscopy (TEM) grids were purchased from 22 
Agar Scientific, UK. Chitosan (200 - 400 kDa) was purchased from Sigma-Aldrich, UK. Atomic force 23 
microscopy (AFM) cantilever tips were purchased from Windsor Scientific, UK. 24 
 25 
2.2. NMR and GPC characterisation 26 
Block ratio composition and molecular weight of the received MPC-DPA block copolymers was confirmed 27 
using 
1
H nuclear magnetic resonance (NMR) spectroscopy and gel permeation chromatography (GPC) using 28 
methods detailed previously (Salvage et al., 2016). 29 
 30 
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2.3. Solvent solubility 1 
The solubility of the MPC-DPA copolymers in organic solvents of differing polarity values (Table 1) was 2 
assessed for a matrix of 31 solvent combinations utilising methanol, ethanol, chloroform, isopropanol, and 3 
acetonitrile, as shown in Table 2. For each solvent combination, copolymer solutions were prepared (40 mg/mL) 4 
and allowed to equilibrate for two days, at room temperate, for dissolution to complete. The copolymer solutions 5 
were then visually assessed, and solubility in each of the 31 solvents designated as one of three British 6 
Pharmacopeia based solubility classes: completely soluble, slightly soluble, and practically insoluble. 7 
 8 
2.4. Nanoprecipitation formation of nanoparticle systems 9 
Copolymer solutions (40 mg/mL) in the 31 solvents (Table 2) were prepared for MPC30-DPA100 and MPC100-10 
DPA100. The nanoprecipitation process was adapted from a published method (Salvage et al., 2015), whereby 11 
aliquots (100 µL) of the copolymer solutions were added drop-wise to 10 mL of phosphate buffer saline (PBS) 12 
(pH 7.4) and stirred (600 rpm) for 4 minutes with a magnetic stir bar (20 mm) to facilitate solvent evaporation. 13 
Copolymer concentration of the prepared nanoparticle systems was 0.4 mg/mL. Independent (n = 3) triplicate 14 
repeats of the experimental work were undertaken. 15 
 16 
2.5. Film-rehydration formation of nanoparticle systems 17 
Copolymer solutions (5 mg/mL) in 6 solvents selected from the 31 solvent matrix (Table 2), based on the 18 
nanoprecipitation data, were prepared for MPC30-DPA100 and MPC100-DPA100. Aliquots (10 mL) of these were 19 
added to 20 mL glass vials, and the solvent removed via evaporation in a Fistreem digital vacuum oven (1000 20 
mbar) at 50 °C for 8 hours. The copolymer films in the glass vials were then rehydrated using 10 mL of PBS (pH 21 
7.4) with constant stirring (200 rpm), via a magnetic stir bar (15 mm), for 1 week at ambient room temperature, 22 
and then sonicated for 15 minutes to reduce the average particle size and polydispersity (Battaglia et al., 2011; 23 
Pegoraro et al., 2014; Sorrell et al., 2014). The resultant samples (5 mg/mL) were further diluted with PBS (pH 24 
7.4) to provide 0.5 mg/mL copolymer nanoparticle systems. Independent (n = 3) triplicate repeats of the 25 
experimental work were undertaken. 26 
 27 
2.6. Nanoparticle system characterisation 28 
 7 
 
The prepared MPC-DPA nanoparticle systems were assessed for particle size, polydispersity, zeta potential, and 1 
particle morphology, using dynamic light scattering (DLS), laser Doppler electrophoresis (LDE), and scanning 2 
transmission electron microscopy (STEM). 3 
 4 
2.6.1 Dynamic light scattering 5 
Particle size (ZAve) and polydispersity (Pd) of the nanoparticle systems were measured in triplicate at 25° C, 6 
with a Malvern Zetasizer Nano ZS90 instrument, using the DLS method detailed previously (Salvage et al., 7 
2016). Samples were examined unfiltered, syringe filtered 0.45 µm, and syringe filtered 0.22 µm. The particle 8 
size data are presented as intensity based hydrodynamic diameters (Dh), with average nanoparticle system 9 
particle size (ZAve) determined via Cummulants analysis, and where multiple particle population peaks were 10 
present within a sample, individual peak average diameters (Dh
1
, Dh
2
, Dh
3
) determined by non-negative least 11 
square (NNLS) analysis. Independent (n = 3) triplicate repeats of the experimental work were undertaken. 12 
 13 
2.6.2. Laser Doppler electrophoresis 14 
Zeta potential of the nanoparticles was determined via LDE, using a Malvern Zetasizer Nano ZS90 instrument at 15 
25 °C, with Malvern DTS 1061 capillary cells and DTS 1235 zetapotential standards. Data consisted of the 16 
average value of three consecutive, 120 seconds, measurements, composed of 12 runs. The LDE technique 17 
measured the electrophoretic mobility of the nanoparticles, and then used the Henry equation (UE = 2ε z ƒ(Ka) / 18 
3η), where UE = electrophoretic mobility, ε = dielectric constant, z = zetapotential, ƒ(Ka) = Henry’s function, 19 
and η = viscosity, to calculate the zeta potential. Independent (n = 3) triplicate repeats of the experimental work 20 
were undertaken. 21 
 22 
2.6.3. Scanning transmission electron microscopy 23 
Particle morphology was investigated via STEM, using a Zeiss SIGMA field emission gun scanning electron 24 
microscope (FEG-SEM) equipped with a Zeiss STEM detector. Working conditions used were; 20 kV 25 
accelerating voltage, 20 µm aperture, and 3 mm working distance. To prepare the STEM samples, 200 mesh 26 
Formvar coated copper TEM grids were plasma treated, 40 seconds at 5 watts, in a Polaron PT7150 plasma 27 
barrel etcher for 30 seconds, to improve surface wettability. Then 1 drop of sample (0.22 µm filtered) was 28 
applied to the TEM grid for 60 seconds, excess wicked way, 1 drop of filtered (0.22 µm) 2% phophotungstic 29 
 8 
 
acid (PTA) (pH 7.4) applied to the TEM grid for 60 seconds, excess wicked away, and then air dried at room 1 
temperature. 2 
 3 
2.7. Atomic force microscopy 4 
Copolymer film morphology and roughness were examined via AFM, using a Digital Instruments Dimension 5 
D3000 AFM, equipped with a Nanoscope 111A controller. The AFM was operated in tapping mode, at a scan 6 
rate of 0.25 Hz, a scan size of 100 µm, and using Nanosensor PointProbe NCH-W cantilever AFM tips. The 7 
copolymer films (5 mg/mL) were prepared by applying 1 drop of copolymer-solvent sample to a 13 mm 8 
diameter glass coverslip. 9 
 10 
2.8. TMC synthesis 11 
The N-trimethyl chitosan chloride (TMC) synthesis was undertaken via nucleophilic substitution using methyl 12 
iodide in a two-step reaction to produce a high degree of quarterisation (DQ %) in accordance with published 13 
protocols (Patrulea et al., 2015; Sahni et al., 2008; Sieval et al., 1998). The chitosan degree of deacetylation 14 
(DDA) (Lavertu et al., 2003), and the TMC degree of quaternisation (DQ) (Patrulea et al., 2015; Thanou et al., 15 
2000), were determined by 
1
H NMR in deuterium oxide (D2O) using a 400 MHz Bruker Ascend spectrometer 16 
and were calculated according to equations 1 and 2, respectively: 17 
 18 
DDA (%) = (
𝐻1𝐷
𝐻1𝐷 +𝐻𝐴𝑐/3
) × 100  ………………. (1) 19 
Where: H1D is the value of the integral for the peak of proton H1 of deacetylation monomer at chemical shift 20 
5.211 ppm; and HAc is the peak of the three protons of acetyl group at chemical shift 2.351 ppm. 21 
 22 
DQ (%) = (
[(𝐶𝐻3)3]
[𝐻]
  ×   
1
9
) × 100 …………… (2) 23 
Where: [(CH3)3] is the value of the integral for the peak of trimethyl amino function [-N+(CH3)3] at chemical 24 
shift 3.3 ppm; and the [H] is the value of the integral for the peaks of the proton H1 of chitosan at chemical shift 25 
4.7 and 5.4 ppm and used as internal standards. 26 
 27 
2.9. Calibration curves for curcumin solubility and loading  28 
To determine the solubility of curcumin in the solvents (ethanol-isopropanol and methanol-ethanol-chloroform-29 
acetonitrile) used for nanoparticle loading (Section 2.10), standard curves were constructed using a PerkinElmer 30 
 9 
 
Lambda 25 UV-Vis spectrophotometer. Curcumin in solvent solutions were prepared (0 – 12 mg/L), the λ max 1 
measured, the absorbance of the dilutions recorded at the λ max, and the standard curves plotted.  Saturated 2 
solutions of curcumin in solvent were then prepared (Baka et al., 2008), filtered (0.22 µm) to remove 3 
undissolved curcumin, diluted to the linear range, the absorbance at λ max measured, and the curcumin solubility 4 
calculated from the standard curves. 5 
To determine curcumin encapsulation and loading efficiency, standard curves were also prepared for curcumin at 6 
pH 1.6 in PBS-methanol (1:9 v/v), as curcumin has been shown to degrade in alkaline conditions (Liu et al., 7 
2012; Wang et al., 1997), and has greater stability in acidic solutions (Tomren et al., 2007). Aliquots (1 mL) of 8 
the curcumin loaded MPC-DPA nanoparticle in PBS formulations (Section 2.10), were then dissolved in 9 mL of 9 
methanol (pH 1.6), diluted to the linear range, the absorbance at λ max measured, the curcumin content 10 
determined from the standard curve, and the encapsulation efficiency and loading capacity calculated from 11 
equations 3 and 4. Independent (n = 3) triplicate repeats of the experimental work were undertaken. 12 
 13 
Encapsulation efficiency (EE%) = [
weight of curcumin in nanoparticles
weight of feed curcumin 
] × 100 ……......(3) 14 
 15 
Loading capacity (LC%) = [
weight of curcumin in nanoparticles
weight of feed copolymer 
] × 100 ……………......(4) 16 
 17 
2.10. Curcumin loaded nanoparticle systems 18 
MPC-DPA nanoparticle systems loaded with curcumin were prepared for formulation 12 (MPC100-DPA100 in 19 
ethanol-isopropanol) and formulation 26 (MPC30-DPA100 in methanol-ethanol-chloroform-acetonitrile) as per the 20 
nanoprecipitation (Section 2.4) and film-rehydration (Section 2.5) samples, using curcumin saturated solvents. 21 
The solubility of curcumin in the solvents used, and the curcumin encapsulation efficiency and loading capacity 22 
of the prepared MPC-DPA nanosystems were determined using standard curves as per Section 2.9. Independent 23 
(n = 3) triplicate repeats of the experimental work were undertaken. 24 
 25 
2.11. TMC coated MPC-DPA nanoparticles 26 
Coating of the MPC-DPA curcumin loaded nanoparticle systems with TMC polymer was undertaken by firstly 27 
preparing samples as per Section 2.10. TMC was then added to the samples at 1 mg/mL
 
with stirring (200 rpm) 28 
for 24 hours to coat the nanoparticles. The TMC coated nanoparticle systems were characterised using the 29 
 10 
 
methods described in Sections 2.6 and 2.9, for particle size and polydispersity, zetapotential, morphology, and 1 
curcumin encapsulation efficiency and loading capacity. Independent (n = 3) triplicate repeats of the 2 
experimental work were undertaken. 3 
 4 
2.12. Fourier transform infrared spectroscopy 5 
To investigate the chemical structure of curcumin, potential interactions between curcumin and the MPC-DPA 6 
copolymers, the structure of MPC-DPA copolymers, chitosan, and the synthesised TMC polymers, Fourier 7 
transform infrared spectroscopy (FTIR) was performed using a PerkinElmer Spectrum 65 FT-IR Spectrometer. 8 
All transmission spectra were obtained at ambient temperature by recording the average of 32 scans in the region 9 
between a wave number 4000 and 650 cm
-1
 with a resolution of 4 cm
-1
. 10 
 11 
3. Results and Discussion 12 
3.1. NMR and GPC characterisation 13 
The composition of the MPC30-DPA100 and MPC100-DPA100 diblock copolymers, confirmed via 
1
H NMR and 14 
GPC, and shown in Fig. 1a and 1b respectively, and Table 3, was consistent with previous reports (Ma et al., 15 
2003; Salvage et al., 2005), indicating good control of polymer synthesis and stability. 16 
 17 
3.2. Solvent solubility 18 
To explore the influence of organic solvent properties, polarity and miscibility in water, upon the formation of 19 
nanoparticles, and the properties of particle size and polydispersity, a matrix comprising 31 organic solvent 20 
combinations containing MPC30-DPA100 and MPC100-DPA100 copolymers (40 mg/mL) were prepared. The 21 
resultant copolymer solutions were visually classified for solubility in Table 4. The polarity value of the solvents 22 
indicated the expected level of polymer solvent interaction, and will also have influenced the contact force, 23 
surface tension, between the MPC-DPA copolymer and solvents, thus influencing the resultant aggregate 24 
structure and homogeneity of the bulk solution (Ye et al., 2015). The data suggested that MPC100-DPA100 25 
copolymer was more soluble in the 31 solvent combinations than MPC30-DPA100, possibly due to the higher ratio 26 
of amphiphilic block copolymer MPC, and thus more hydrophilic nature. 27 
  28 
3.3. Nanoprecipitation formation of nanoparticle systems 29 
 11 
 
For MPC30-DPA100 nanoparticles in PBS (pH 7.4), formed via nanoprecipitation from the 31 solvent 1 
combinations, DLS analysis revealed a wide range of average particle sizes (ZAve) and polydispersity (Pd) 2 
values, as seen in Table 5. The particle sizes produced were consistent with those of micelles, polymersomes, 3 
and high-order assemblies (Du et al., 2005; Pearson et al., 2013). Exceptions were formulations 3, 4, 13 and 14 4 
which did not produce measurable nanoparticles, which correlated with the solvent solubility data (Table 4), 5 
indicating polymer insolubility in those solvent combinations. Additionally, formulations 10, 17, 19, and 25 6 
resulted in loss of nanoparticle presence upon filtration, principally due to exclusion of large particle aggregates. 7 
Similar observation was noted for MPC100-DPA100 nanoparticle systems, except for formulations 3, 4 and 13 as 8 
seen in Table 5, however there were no filtration associated total particle losses, possibly due to the more 9 
hydrophilic nature of the MPC100 block relative to the MPC30 block. Regarding the filtration process,  using 0.45 10 
and 0.22 µm filters, the average particle size and polydispersity of the MPC-DPA nanoparticles was reduced 11 
upon passing through the filter, which was in agreement with previous work (Salvage et al., 2015, 2016). 12 
Without filtration MPC30-DPA100 nanoparticles displayed larger mean particle sizes compared to MPC100-DPA100 13 
nanoparticles. However, after filtration (0.22 µm), MPC100-DPA100 produced larger nanoparticles with a higher 14 
polydispersity compared to MPC30-DPA100. These results were not unexpected, as the MPC100-DPA100 15 
copolymer structure has a higher degree of amphiphilic MPC block polymer compared to MPC30-DPA100, and 16 
the findings were in agreement with previous reports of degree of polymerisation influencing particle size and 17 
morphology when using the same organic phase (Patikarnmonthon, 2013). In summary, these data indicated that 18 
particle size was dependent upon the type and nature of organic solvent combination used, could be refined with 19 
filtration, and was in agreement with previous reports of solvent choice effects (Bilati et al., 2005; Salvage et al., 20 
2015). 21 
In order to select suitable comparators against the film rehydration process, assessment of the post-filtration 22 
(0.22 µm) data, (Table 5 and Table 6), indicated that nanoprecipitation formulations 15, 24, 26 for MPC30-23 
DPA100, and 12, 16, 29 for MPC100-DPA100, had the largest mean particle sizes combined with the lowest 24 
polydispersity values, and were thus chosen.  25 
 26 
3.4. Film-rehydration formation of nanoparticle systems 27 
The MPC-DPA film rehydration samples for solvent combinations 15, 24, 26, (MPC30-DPA100) and 12, 16, 29 28 
(MPC100-DPA100) were formed via solvent casting of the polymer film, followed by rehydration in PBS (pH 7.4), 29 
with stirring, over a 7 day period. It can be seen from Figure 2 that there were visible differences in the rate of 30 
 12 
 
film rehydration and polymer solubilisation between the polymers. Immediately after addition of the PBS (t = 0) 1 
MPC100-DPA100 polymer films began to hydrate, whilst the less hydrophilic MPC30-DPA100 did not (Figure 2a). 2 
This slower rate of rehydration was evident for MPC30-DPA100 throughout the subsequent experimental time 3 
course (Figure 2b-d), until apparent full rehydration was reached at day 7 (t = 7) (Figure 2e). There was also 4 
visual evidence suggesting that the solvent used for casting influenced rate of film rehydration. To investigate 5 
this further, AFM analysis of the polymer films was undertaken. 6 
The AFM data indicated that the film structure and surface morphology, of the copolymer films, were different 7 
when using the selected solvent combinations, between and within the two copolymers, as shown in Table 7 and 8 
Figure 3. In addition, it was evident that the surface roughness measurement data was greater for formulations 9 
12, 15, 24 and 29 (Table 7), which contained isopropanol, but no chloroform, relative to formulations 16 and 26, 10 
which contained chloroform, but no isopropanol. As seen in Table 1, Isopropanol had a higher viscosity and 11 
boiling point than chloroform, and these data illustrated that solvent properties can influence copolymer 12 
conformations when drying, and affect the resultant copolymer film topology. Furthermore, the higher level of 13 
film surface roughness can lead to greater adhesive strength of the copolymer films (Bowen et al., 1998) , and 14 
therefore rehydration of the film, and creation MPC-DPA nanoparticles, may require an increased stirring shear 15 
rate or time, as seen in Figure 2. 16 
Following the 7 day film rehydration, samples underwent sonication for 15 mins to reduce the heterogeneous 17 
morphology of nanoparticles in the systems (Yealland, 2015), followed by DLS particle size measurement and 18 
STEM imaging of the nanoparticles. As seen with the nanoprecipitation samples, MPC30-DPA100 nanoparticles 19 
formed by film rehydration possessed larger average particle sizes, compared to the MPC100-DPA100, without 20 
filtration as shown in Table 8. This may have been due to the hydrophobic effect of DPA100 in the copolymer 21 
being stronger than the amphiphilic effect of MPC30, and thus consistent with the slower hydration observed 22 
(Figure 2) and resultant larger diameter nano-assemblies. However, when samples were filtered (0.45 and 0.22 23 
µm), the particle sizes and polydispersity values were greatly reduced for both MPC30-DPA100 and MPC100-24 
DPA100 samples, resulting in average diameters in the 120 – 150 nm size range, which was consistent with MPC-25 
DPA polymersome sizes (Du et al., 2005). 26 
In summary, the DLS data (Table 8), indicated that filtration (0.22 µm) of MPC-DPA film rehydration samples 27 
offers the potential to controllably produce nanoparticles of low polydispersity, with good reproducibility, and 28 
the size viewed a suitable for inhalation delivery applications with maximum therapeutic efficacy (Cipolla et al., 29 
 13 
 
2013; Garbuzenko et al., 2014; Gratton et al., 2008; Hu et al., 2014; Koshkina et al., 2001; Kuzmov and Minko, 1 
2015; Ungaro et al., 2012).  2 
 3 
3.5. Comparison of nanoprecipitation vs film rehydration 4 
The methods used to create MPC-DPA nanoparticles, with or without drug loading, were nanoprecipitation and 5 
film rehydration, as described earlier, which have specific properties and requirements associated with each 6 
(Battaglia and Ryan, 2006; Messager et al., 2014). For example, the nanoprecipitation method is a bottom-up 7 
procedure which assembles nanoparticles from copolymer molecules via the rapid injection of dissolved 8 
copolymer organic phase into an aqueous phase. Due to using free moving molecules, this method is a fast 9 
production procedure, capable of reproducibly forming nanoparticles of low polydispersity. In contrast, the film 10 
rehydration method is a top-down approach, and depends upon transition of the bulk copolymer molecules from 11 
dried, cast film, state, through a copolymer swelling phase, to formation of dispersed polymer nanoparticles, 12 
which are primarily polymersomes. These often display, large, micron, particle scale, and require mechanical 13 
energy input to form, such as high shearing and stirring rates, and sonication. This method has some 14 
disadvantages, for example a long processing and formation time, high energy input, and in some cases  is not 15 
suitable for encapsulation of heat sensitive drugs (Bilati et al., 2005; Messager et al., 2014; Sadeghi et al., 2016; 16 
Schubert and Muller-Goymann, 2003) 17 
In this current study, the nanoprecipitation data and film-rehydration data suggest that there were apparent 18 
differences in the size and polydispersity of the nanoparticles formed via the contrasting methods.  Thus, when 19 
these parameters were compared for the MPC30-DPA100 formulations 15, 24, 26, and the MPC100-DPA100 20 
formulations 12, 16, 29, that had been prepared via the two methods, there were indeed clear particle size and 21 
polydispersity shifts evident, as shown in Figures 4a, 4b, and 4c. The more hydrophobic nature of MPC30-22 
DPA100 initially lead to the formation of larger nanoparticles, as the hydrophobicity can impede particle 23 
aggregation in aqueous solutions  (Bilati et al., 2005). However, following the 0.22 µm filtration process, the 24 
MPC100-DPA100 nanoparticles also displayed a larger nanoparticle size, possibly due to a thicker outer corona on 25 
the particles resulting from the MPC block length, with MPC100 being longer than MPC30 (Giacomelli et al., 26 
2006; Salvage et al., 2005). 27 
Additionally, when the two methods of nanoparticle formation without filtration were compared, the film 28 
rehydration method resulted in the formation of larger nanoparticles, with lower reproducibility, as seen in 29 
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Figure 4a, and also increased solution turbidity. This may have been the result of the copolymer concentration 1 
being 5 mg/mL for film rehydration, in contrast to the lower 0.4 mg/mL concentration used for 2 
nanoprecipitation. These results were consistent with Bilati et al. (2005) and Salvage et al. (2015, 2016) in that 3 
they displayed an increase in the particle size, when polymer concentration was increased. To determine the 4 
morphology of the nanoparticles formed, and establish the presence of either micelles or polymersomes, the 5 
MPC30-DPA100 formulations (15, 24, 26) and MPC100-DPA100 formulations (12, 16, 29) prepared by the two 6 
methods employed, nanoprecipitation and film-rehydration, were examined using STEM. As seen in Figures 5 7 
and 6, both copolymers were successful in forming nanoparticles in the two formation processes. For the 8 
nanoprecipitation samples, (Figure 5), STEM analysis indicated that these consisted predominately of small 9 
unilamellar vesicles with a spherical morphology and size consistent with polymersomes. However, for the film 10 
rehydration samples, a mixture of particle morphologies were observed, with polymersome sized nanoparticles 11 
present, as evidenced by the DLS data (Figure 4c), together with larger polymer aggregates with irregular 12 
structures and elongated edges, as shown in Figure 6. This was consistent with previous reports of film 13 
rehydration particle population complexity (Robertson et al., 2016), where exploration and purification of film 14 
rehydration particle populations was undertaken. The STEM data was largely consistent with the DLS data, in 15 
that there was a visible difference in nanoparticle size between all formulations due to the different methods of 16 
formation, and the copolymer compositions. Furthermore, the STEM images (Figures 5 and 6) suggested that 17 
nanoprecipitation was more effective at forming a homogeneous population of polymersomes, compared with 18 
film rehydration. This was possibly due to the copolymer being molecularly dissolved in the organic phase 19 
immediately prior to nanoprecipitation, therefore the forces holding the copolymer chains together were weaker 20 
(Ye et al., 2015) and thus allowed rapid nanoparticle formation. It appeared from Figure 9 that MPC100-DPA100 21 
formed polymer aggregates with thicker particle coronas than MPC30-DPA100, which may have been the result of 22 
MPC100-DPA100 having a higher degree of polymerisation MPC block (Du et al., 2005).  The morphology of 23 
MPC-DPA polymersomes, as well as aggregation style, can be influenced by several factors, including, the 24 
formation process, nature of organic solvents used, the hydrophobic to hydrophilic balance of copolymer blocks, 25 
polymer concentration, and stirring speed and duration (Ayen et al., 2011). According to the DLS data (Figures 26 
4a, 4b, and 4c) and STEM images (Figures 5 and 6) for characterisation of the MPC-DPA nanoparticles, the 27 
formulations 12 and 26, for both MPC100-DPA100 and MPC30-DPA100, possessed a large particle size together 28 
with low polydispersity, and spherical morphology, and were therefore selected for subsequent curcumin 29 
loading. 30 
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 In summary, the solvent, non-solvent, and ratio used, together with copolymer composition, can affect the 1 
resultant nanoparticle size and morphology. Additionally, STEM data (Figures 5 and 6) suggested that, in this 2 
instance, nanoprecipitation was more effective at forming homogeneous populations of vesicle morphology 3 
nanoparticles, polymersomes, than the film rehydration method which requires subsequent particle fractionation 4 
and purification before use (Robertson et al 2016). 5 
 6 
3.6. TMC synthesis 7 
The physicochemical properties of chitosan can be affected by the degree of deacetylation, and the percentage of 8 
deacetylated and acetylated monomer plays an important role in TMC synthesis efficacy. Therefore, before TMC 9 
synthesis was undertaken, the degree of deacetylation (DDA%) of chitosan was calculated (Lavertu et al., 2003). 10 
The 
1
H NMR spectrum of the chitosan polymer (Figure 7a), which consisted of acetylated and deacetylated 11 
monomers, was consistent with  previously reported spectra (Lavertu et al., 2003). As such, the chemical shift at 12 
2.351 ppm was attributed to the three protons of acetyl group (-CO-CH3) in acetyl units (H-Ac), while the 13 
chemical shifts at 4.918 and 5.211 ppm were assigned to protons H1 for both acetylated (H1-A) and deacetylated 14 
(H1-D) units. Additionally, the chemical shifts between 3.916 and 4.225 ppm corresponded to protons H2, H3, 15 
H4, H5, and H6 (H2-6) of glycosidic ring of chitosan, the chemical shift at 3.518 ppm was assigned to proton H2 16 
in deacetylated units, and the shift at 4.733 ppm belonged to the solvent (HOD) proton (Lavertu et al., 2003). 17 
According to the proposed shift assignments within the NMR spectra (Figure 7a) and the equation (1), the degree 18 
of deacetylation (DDA) of chitosan used for TMC synthesis was 81%. 19 
The TMC was synthesized from high molecular weight chitosan using the two step method (Polnok et al., 2004; 20 
Sahni et al., 2008; Sieval et al., 1998) the resultant polymer was a white powder, which was soluble in water, the 21 
1
H NMR spectra for the TMC is shown in Figure 7b. The chemical shifts at 2.55, 3.05, and 3.8 ppm were 22 
assigned to –NHCH3, -N(CH3)2 and –N
+
(CH3)3 groups from the TMC structure, respectively, and was consistent 23 
with previous reports (Hansson et al., 2012; Patrulea et al., 2016; Sieval et al., 1998). Additionally, the chemical 24 
shifts at 4.8 and 5.25 ppm that were assigned to the H1 proton of chitosan and its derivatives, as described in 25 
previous reports (Hansson et al., 2012; Patrulea et al., 2015; Thanou et al., 2000), had disappeared. According to 26 
the proposed shift assignments, and using the equation (2), the degree of quaternization (DQ) of TMC after the 27 
two step synthesis was high, at 75%, and this result corresponded well with other reports  (Patrulea et al., 2015; 28 
Polnok et al., 2004; Sieval et al., 1998; Thanou et al., 2000). 29 
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 1 
3.7. Assessment the calibration curves and solubility of curcumin 2 
The lambda max (λ max) of curcumin solutions was determined via UV-Vis spectroscopy as 428 nm, and used 3 
to measure the maximum solubility of curcumin, and also the encapsulation efficiency of drug loading with 4 
nanoparticles from formulations 12 and 26 for MPC100-DPA100 and MPC30-DPA100. Linearity was evident from 0 5 
– 12 mg/L curcumin concentration in formulation 12, (ethanol-isopropanol) solvent mix (R2 = 0.9999) and also 6 
in formulation 26, (methanol-ethanol-chloroform-acetonitrile) solvent mix (R
2
 = 0.9997), and from 0 – 10 mg/L 7 
for the PBS-methanol (pH 1.6) mix (R
2
 = 0.9996) where y = 0.1462x + 0.0033. Using the standard curves, the 8 
solubility of curcumin in formulation 12 (ethanol-isopropanol), y = 0.1239x + 0.0114, was determined as 3.49 ± 9 
0.14 g/L, and in formulation 26 (methanol-ethanol-chloroform-acetonitrile), y = 0.1315x + 0.0141, as 24.54 ± 10 
1.26 g/L, respectively, indicating solvent associated solubility differences. 11 
 12 
3.8. Curcumin loading and TMC coating 13 
As described earlier, two contrasting methods, nanoprecipitation and film rehydration, were used to prepare 14 
curcumin loaded MPC-DPA nanoparticles. The size and morphology of these nanoparticles were then assessed, 15 
together with the drug loading efficiency. The DLS data, as shown in Table 9, for nanoparticles prepared by 16 
nanoprecipitation, indicated that mean particle diameters were circa 154 nm and 188 nm when empty, and 142 17 
nm and 175 nm after loading using curcumin saturated solvents, for formulations 26 (MPC30-DPA100) and 12 18 
(MPC100-DPA100) respectively. These reductions in mean particle diameter may be the result of the hydrophobic 19 
curcumin acting as an increased focus of attraction for the hydrophobic DPA copolymer domains during the 20 
hydrophobic effect partitioning of curcumin into the nanoparticles, and hence causing nanoparticle diameter 21 
contraction. The addition of TMC (1 mg/mL) to the aqueous nanoprecipitated nanoparticle suspensions resulted 22 
in decreased mean particle diameters of circa 136 nm and 162 nm for formulations 26 and 12 respectively, 23 
possibly due to filtration (0.22 µm) associated particle exclusion, extrusion, and average size reduction, or the 24 
TMC attenuating the previously fully hydrated, and nanoparticle surface extended, MPC copolymer branches. 25 
Polydispersity values ranged from 0.08 to 0.18, with formulation 26 (MPC30-DPA100) displaying the lower 26 
values. The film rehydration prepared samples were circa 139 nm and 154 nm when empty, and circa 153 nm 27 
and 164 nm when loaded with curcumin, for formulations 26 (MPC30-DPA100) and 12 (MPC100-DPA100) 28 
respectively, as seen in Table 10. This was the inverse of the effect seen with nanoprecipitation, with the 29 
nanoparticles becoming larger in this instance, however given the apparent complexity of film rehydration 30 
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nanoparticle morphologies and populations, the greater amount of curcumin loading achieved, and the possibility 1 
that curcumin may have resulted in an increased level of copolymer nanoparticle aggregation, this could thus 2 
explain the increased diameters observed. In a similar mode to the nanoprecipitation samples, addition of TMC 3 
to the aqueous film rehydration prepared nanoparticle suspensions, again resulted in mean dimeter size 4 
reductions, to circa 132 nm and 157 nm. Polydispersity values for formulations 26 (MPC30-DPA100) and 12 5 
(MPC100-DPA100) ranged from 0.14 to 0.34, with formulation 12 displaying the lower values. 6 
Regarding the surface zeta potential of the unloaded and loaded nanoparticles, Tables 9 and 10, these were 7 
initially slightly negative, and close to zero mV when the standard deviation was taken into consideration for 8 
unloaded nanoparticles,  due to the presence of the amphiphilic groups in MPC polymer structure (Goda et al., 9 
2007), and subsequent curcumin loading shifted the values further to negative. However, following TMC coating 10 
of the nanoparticles the zeta potential values shifted and increased to positive values, as the TMC is a  11 
polycationic polymer, and as such coated the MPC-DPA nanoparticles due to attractive electrostatic forces 12 
between cationic amine groups in TMC polymer and amphiphilic phosphorylcholine groups in MPC (Patrulea et 13 
al., 2015; Sahni et al., 2008; Sieval et al., 1998). The shift to positive zeta potential values was more pronounced 14 
and consistent with the MPC30-DPA100 polymer, as the smaller MPC30 group was unable to counter the positive 15 
charge addition of the TMC, whilst the larger MPC100 group polymer was able to more effectively reduce the 16 
TMC addition effects on particle surface charge. 17 
The curcumin encapsulation efficiency and loading capacity of the MPC-DPA nanoparticles were low, and 18 
indeed undetectable via UV-Vis for MPC30-DPA100, as seen in Tables 9 and 10, possibly due to the differing 19 
amounts of curcumin present in the saturated solutions used, 24.54 g/L and 3.49 g/L curcumin for MPC30-20 
DPA100 and MPC100-DPA100, respectively, and resulting from the different levels of curcumin solubility in the 21 
solvents used.  When the organic solvent phase of formulation 26, containing MPC30-DPA100, was added to the 22 
aqueous PBS phase, it may have precipitated due to formation of a solid dispersion of large micro particles. This 23 
would have been the result of the high binding affinity hydrophobic forces between the concentrated curcumin 24 
(24.54 g/L) and the DPA copolymer domain (Onoue et al., 2014, 2013; Suzuki et al., 2016). The curcumin 25 
nanoparticles would then be lost by filtration (0.22 µm) immediately prior to UV-Vis measurement. 26 
In contrast, the MPC100-DPA100 copolymer formed curcumin encapsulated nanoparticles, having used a lower 27 
concentration of curcumin (3.49 g/L), with UV-Vis detectable and quantifiable levels of curcumin entrapped 28 
(Tables 9 and 10). Previous reports have indicated that curcumin inhibits the migration, invasion, proliferation, 29 
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and viability of A549, CL1-5, and H1299 human lung cancer cell lines (Pillai et al., 2004; Chen et al., 2008; Lin 1 
et al., 2009; Patil et al., 2015). For example, Chen et al., 2008 reported a curcumin concentration dependent 2 
effective range of 1 – 20 µM against A549 and CL1-5 cells, and more recently Patil et al., 2015 found that 3 
curcumin at 2.9 µg/mL inhibited A549 cell growth. In this current study, the film rehydration prepared MPC100-4 
DPA100, formulation 12, nanoparticle data shown  in Table 10 indicates that curcumin loading of 6.86 µg/mL (18 5 
µM) and 42.57 µg/mL (115 µM) was achieved for MPC-DPA nanoparticles, and TMC coated MPC-DPA 6 
nanoparticles respectively. Therefore both of these have sufficient curcumin loading to be considered potentially 7 
effective against human lung cancer cells. The nanoprecipitation prepared MPC100-DPA100, formulation 12, 8 
nanoparticle data shown in Table 9 indicates that curcumin loading at 0.92 µg/mL (2.5 µM) and 0.85 µg/mL (2.3 9 
µM) were achieved for MPC-DPA nanoparticles, and TMC coated MPC-DPA nanoparticles respectively, and 10 
these levels of curcumin loading are located at the lower end of the effective range (1 – 20 µM) suggested by 11 
Chen et al., 2008. However, in this current study the nanoprecipitation was undertaken at a MPC-DPA 12 
copolymer in PBS concentration of 0.4 mg/mL, whilst it has been reported previously (Salvage et al., 2016) that 13 
MPC100-DPA100 nanoparticles successfully form in PBS at a copolymer concentration of 2 mg/mL. Therefore it 14 
should be possible to increase the copolymer concentration, and thus increase curcumin loading, 5-fold, to circa 15 
4.6 µg/mL (12.5 µM) and 4.25 µg/mL (11.5 µM) for MPC-DPA nanoparticles, and TMC coated MPC-DPA 16 
nanoparticles respectively, both of which would be within the range reported by Chen et al., 2008 and Patil et al., 17 
2015, as effective against human lung cancer cells. 18 
The morphological study of the curcumin loaded MPC-DPA nanoparticles, using STEM, confirmed that 19 
MPC100-DPA100 copolymer successfully encapsulated curcumin and formed nanoparticles with an irregular 20 
spherical morphology using curcumin at low concentration (3.49 g/L), as seen in Figures 8c and 9c, and were 21 
consistent with previous reports of curcumin loaded polymer micelles (Patil et al., 2015). In contrast, the STEM 22 
imaging (Figures 8 and 9) of MPC30-DPA100 copolymer nanoparticles and curcumin, revealed an apparent solid 23 
dispersion formation when using curcumin at high concentration (24.54 g/L), for both the nanoprecipitation 24 
(Figure 8a) and film rehydration (Figure 9a) preparation methods.  Interestingly, the addition of TMC to all 25 
formulations produced morphological changes in the nanoparticles, with the appearance of vesicle-like droplet 26 
morphologies, as seen in Figures 8b, 8d, 9b and 9d. These were suggestive of the TMC polymer coating the 27 
outside of the MPC-DPA nanoparticles, and were morphologically consistent with recent reports of 28 
poly(ethylene oxide) based polymersomes (Bartenstein et al., 2016).  29 
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One of the key requirements for an effective nanoparticle based drug delivery system is the control of size and 1 
drug loading, as these parameters are central to achieving good biodistribution and therapeutic efficacy after 2 
administration. Four techniques, filtration, centrifugation, size-exclusion chromatography, and density gradient 3 
centrifugation, have been reported as successful for purifying and separating heterogeneous nanoparticle 4 
solutions into homogenous fractions (Robertson et al., 2016). Therefore, where necessary, the curcumin loaded 5 
MPC-DPA nanoparticles developed in this current study, could be further separated and optimised into distinct 6 
sizes and shape fractions in order to facilitate their future development for a range of biomedical applications, 7 
including inhalation drug delivery. Additionally, the successful coating of the curcumin loaded MPC-DPA 8 
nanoparticles with TMC polymer may provide key advantages such as, improved cell permeation and increased 9 
curcumin absorption into human cells (Chen et al., 2016; Guan et al., 2012; Panya et al., 2010; Sahni et al., 2008; 10 
Zhang et al., 2013).  In summary, MPC100-DPA100 nanoparticles were formed via nanoprecipitation and film 11 
rehydration that were of pulmonary delivery size, contained curcumin at anti-tumour concentrations, and could 12 
be coated with TMC to further enhance cellular uptake and delivery. 13 
 14 
3.9. Fourier transform infrared spectroscopy 15 
The vibrational spectrum of the curcumin was consistent with previous reports (Darandale and Vavia, 2013; 16 
Mohan et al., 2012; Zhang et al., 2013) and revealed characteristic main bands, as shown in Figure 10a. A sharp 17 
peak at 3508 cm
-1
 indicated the presence of the stretching vibration of the phenolic-OH group, and a sharp peak 18 
at 1626 cm
-1
 was attributed to vibration of the carbonyl C=O group. The peak at 1601 cm
-1
 was assigned to the 19 
enol C=O stretching, and the peak at 1504 cm
-1
 was the symmetric stretching vibration of an aromatic ring (C=C 20 
ring). Moreover, alkane C-H group bending vibration was at 1427 cm
-1
, while aromatic C-O stretching vibration 21 
was seen at 1272 cm
-1
. C-O-C stretching vibration and aromatic ring-CH bending vibrations were found at 1024 22 
and 961 cm
-1
, respectively, and between 900 and 650 cm
-1
 a forest of out of plane vibration for CH and CH2 23 
(Darandale and Vavia, 2013; Patil et al., 2015; Pecora et al., 2016).  24 
The structure of MPC30-DPA100 and MPC100-DPA100 copolymers were also characterised with FTIR. The main 25 
bands in both are presented in Figure 10b, the broad peak at 3500-3000 cm
-1
 may be stretching vibration of 26 
nitrogen in primary and secondary amine groups (Gao et al., 2013; Zheng et al., 2013), it may also illustrate the 27 
presence of residual moisture, bound or unbound water adsorption, in the copolymer as the carbonyl group in the 28 
copolymer structure can strongly interact with water molecules and produce hydrogen bonding (Sammon et al., 29 
1998; Szakonyi and Zelkó, 2012). The peaks at 2963 and 2879 cm
-1
 are the stretching vibration of C-H and -30 
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CH2, respectively (Furuzono et al., 2000; Gao et al., 2013), and the sharp peaks at 1724 and 1479 cm
-1
 the 1 
carbonyl C=O and C-H bonds. The stretching vibration of the C-N group and ester band C-O group were 2 
observed at 1145 and 1064 cm
-1
 (Faccia and Amalvy, 2013). To confirm the chemical groups in MPC and DPA 3 
monomers, the peak of the methane group (CH3)2- CH- in poly DPA was observed at 2963 cm
-1
 (Faccia and 4 
Amalvy, 2013; Furuzono et al., 2000; Gao et al., 2013; Yan and Ishihara, 2008; Zheng et al., 2013), while peaks 5 
at 1231, 964 and 786 cm
-1
 were attributed to –POCH2-, -N+(CH3)3 and C-O-P groups in poly MPC, respectively. 6 
The FTIR spectra (Figure 10b) of  MPC30-DPA100 and MPC100-DPA100 copolymers were principally the same, 7 
but the intensity of the peak around (3500-3000) cm
-1
 was stronger for MPC100-DPA100 than MPC30-DPA100, due 8 
to hygroscopic nature of MPC which over a broad solution pH range can hydrate with circa 15 water molecules 9 
(Chen et al., 2007; Ishihara et al., 1992; Yang et al., 2016; Yaseen et al., 2006). 10 
FTIR spectra of chitosan and TMC are presented in Figure 10c. For chitosan, the broad peak at the range (3500-11 
3000) cm
-1
 corresponded to the combined stretching vibration bands for –OH and –NH2 groups while the peak at 12 
2872 cm 
-1
 was the asymmetrical and symmetrical stretching vibration of C-H in the glyosidic ring. Additionally, 13 
the bands at 1650 and 1590 cm
-1
 were attributed to –NHCOCH3 group stretching vibration and N-H group 14 
bending from chitosan structure, correspondingly. The strong band at 1024 cm
-1
 was consistent with the C-O-C 15 
peak  (Nazar et al., 2011; Patrulea et al., 2016). Regarding the TMC polymer spectrum in Figure 10c, it was clear 16 
that the insertion of trimethyl groups in chitosan structure lead to increased intensities of the main peaks such as 17 
the intensity of methyl group C-H in two positions: the stretching bands (3000-2900 cm
-1
) as well as the bending 18 
bands at (1500-1470 cm
-1
), and the amide stretching bands (1652 cm
-1
) (de Britto et al., 2012; Hansson et al., 19 
2012; Nazar et al., 2011; Patrulea et al., 2016). The results of FTIR analysis of TMC polymer (Figure 10c) 20 
corresponded with NMR analysis where all sets of bonds in the chemical structure were visible as evidence of 21 
successful synthesis of TMC from chitosan.  22 
When the FTIR data for all components were observed (Figure 10d) there were no discernible shifts of resonance 23 
within the physical mixtures of either curcumin or TMC with the MPC-DPA copolymers. However, there were 24 
apparent differences when the FTIR of pure curcumin was compared to that of curcumin mixed with MPC30-25 
DPA100 or MPC100-DPA100 copolymers in the organic solvents combinations used to prepare formulations 12 and 26 
26, as shown in Figure 10e. In this instance, there were shifts in the majority of peak positions in all of the 27 
mixtures examined. In addition, the sharp peak at 3509 cm
-1
, assigned to phenolic-OH groups in curcumin, 28 
disappeared in the both formulation 12 and 26 FTIR spectra. This suggested that there had been an interaction 29 
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when mixing curcumin at maximum solubility, 24.30 and 3.44 mg/mL, with MPC30-DPA100 and MPC100-DPA100 1 
copolymers at 40 mg/mL in the solvents for formulations 12 and 26 during nanoprecipitation and film 2 
rehydration. This interaction was more distinct with MPC30-DPA100 in formulation 26, due the higher 3 
concentration of curcumin (24.30 mg/mL) with the higher ratio of hydrophobic DPA polymer, compared to 4 
formulation 12, which contained only 3.44 mg/mL of curcumin for the same ratio of MPC100 and DPA100 5 
polymers. Furthermore, this interaction may be attributed to intermolecular hydrogen bonding between the 6 
phenolic-OH groups in curcumin seen at 3508 cm
-1
 and amine groups as well as carbonyl groups in MPC-DPA 7 
copolymer structure at 3500-3000 and 1724 cm
-1
, respectively. 8 
The large amount of curcumin used in formulation 26 may have contributed to formation of a solid dispersion 9 
between the MPC30-DPA100 copolymer and curcumin after evaporation of the organic solvents. This would be 10 
due to high affinity binding between curcumin and the DPA monomer, via hydrophobic forces, and the high 11 
concentration of curcumin used. The solid dispersion, being insoluble in water, was thus unable to form 12 
polymersome morphologies when added to aqueous PBS solution (Gupta and Dixit, 2011; Paradkar et al., 2004). 13 
Furthermore, when the FTIR spectra for the same mixture of curcumin and MPC-DPA copolymer were 14 
compared, with the different concentrations used for nanoprecipitation and film rehydration, the interaction was 15 
more detectable, with peak intensity reduced, in the mixture used for nanoprecipitation. This may be due to the 16 
higher concentration of copolymer (40 mg/mL) used in nanoprecipitation process (Figures 10e (iv) and 10e (vi)) 17 
compared to the film rehydration (5 mg/mL) method (Figures 10e (v) and 10e (vii). The FTIR data were 18 
consistent with the STEM image (Figures 8 and 9), encapsulation efficiency, and drug loading capacity data 19 
(Tables 9 and 10) for curcumin loaded nanoparticles,  which suggested the formation of solid dispersions of 20 
curcumin and MPC30-DPA100 copolymer, containing large insoluble particles. In summary, MPC100-DPA100 21 
copolymer displayed a more effective ability to form curcumin encapsulated nanoparticles when using curcumin 22 
at low concentration, and therefore the drug quantity used for entrapment has the potential to affect the 23 
micellisation and nanoparticle formation processes with MPC-DPA copolymers.  24 
 25 
4. Conclusions 26 
In conclusion, this current work reported for the first time, by application of a 31 solvent matrix, a novel and 27 
comprehensive investigation of solvent choice effects on nanoprecipitation assembled MPC-DPA nanoparticles. 28 
The resultant novel data was used to select candidate systems deemed as potentially suitable for inhalation drug 29 
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delivery applications, based on particle size and polydispersity, for further assessment and comparison with 1 
equivalent film-rehydration MPC-DPA assembled systems. Analysis of this second novel data set afforded 2 
further selective testing in the form of curcumin loading and TMC particle coating, leading to the optimisation of 3 
MPC-DPA nanoparticle systems with curcumin loading levels reported as effective against human lung cancer 4 
cells. The systems prepared and optimised are thus considered suitable for progression to inhalation delivery 5 
characterisation, and in-vitro human lung cancer cell drug delivery testing. It is believed that this is the first 6 
report of curcumin loaded MPC-DPA nanoparticle systems, illustrating their potential to act as a delivery vehicle 7 
for the emerging therapeutic compound curcumin. In doing so, this study contributed towards development of 8 
novel curcumin nano-formulations with potential pharmaceutical applications for pulmonary delivered treatment 9 
of human lung cancer, and is thus of societal interest, benefit, and significance. 10 
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Tables 1 
 2 
Table 1 3 
Classification of organic solvent properties (adapted from (Smallwood, 1996)). 4 
Solvent Name Polarity Value 
Solubility in Water 
(25
°
C, % w/w) 
Absolute Viscosity 
(25 
°
C, Cp) 
Boiling Point 
(
°
C) 
Methanol 76.2 Total 0.6 64 
Ethanol 65.4 Total 1.08 78 
Isopropanol 54.6 Total 2.0 82 
Acetonitrile 46.0 Total 0.38 81.6 
Chloroform 25.9 0.82 0.57 61 
 5 
Table 2 6 
The 31 solvent combination matrix used to assess MPC-DPA copolymer solubility at 40 mg/mL 7 
Solvent combination ratios 
# Methanol Ethanol Chloroform Acetonitrile Isopropanol Ratio 
1 1 0 0 0 0 1:0:0:0:0 
2 0 1 0 0 0 0:1:0:0:0 
3 0 0 1 0 0 0:0:1:0:0 
4 0 0 0 1 0 0:0:0:1:0 
5 0 0 0 0 1 0:0:0:0:1 
6 1 1 0 0 0 1:1:0:0:0 
7 1 0 1 0 0 1:0:1:0:0 
8 1 0 0 1 0 1:0:0:1:0 
9 1 0 0 0 1 1:0:0:0:1 
10 0 1 1 0 0 0:1:1:0:0 
11 0 1 0 1 0 0:1:0:1:0 
12 0 1 0 0 1 0:1:0:0:1 
13 0 0 1 1 0 0:0:1:1:0 
14 0 0 1 0 1 0:0:1:0:1 
15 0 0 0 1 1 0:0:0:1:1 
16 1 1 1 0 0 1:1:1:0:0 
17 1 1 0 1 0 1:1:0:1:0 
18 1 1 0 0 1 1:1:0:0:1 
19 0 1 1 1 0 0:1:1:1:0 
20 1 0 1 1 0 1:0:1:1:0 
21 1 0 1 0 1 1:0:1:0:1 
22 1 0 0 1 1 1:0:0:1:1 
23 0 1 1 0 1 0:1:1:0:1 
24 0 1 0 1 1 0:1:0:1:1 
25 0 0 1 1 1 0:0:1:1:1 
26 1 1 1 1 0 1:1:1:1:0 
27 0 1 1 1 1 0:1:1:1:1 
28 1 0 1 1 1 1:0:1:1:1 
29 1 1 0 1 1 1:1:0:1:1 
30 1 1 1 0 1 1:1:1:0:1 
31 1 1 1 1 1 1:1:1:1:1 
 8 
 9 
 10 
 11 
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 1 
Table 3 Molecular weight (Mn and Mw) and polydispersity (Mw/Mn) of MPC-DPA diblock copolymers 2 
determined via 
1
H NMR and organic GPC 3 
 4 
MPC30-DPA100 Mn Mw Mw/Mn 
Target (g/mol) 30190 - - 
1
H NMR 30190 - - 
GPC 33050 33890 1.03 
MPC100-DPA100 Mn Mw Mw/Mn 
Target (g/mol) 50860 - - 
1
H NMR 50860 - - 
GPC 50060 50500 1.01 
 5 
Table 4 6 
Visual classification of MPC-DPA copolymer solubility in solvents. See Table 2 for solvent formulation details. 7 
Solubility visual classification of MPC-DPA copolymers 
# 
Solvent 
MPC100 – DPA100 MPC30 – DPA100 
Combination 
1 1:0:0:0:0 Completely soluble Slightly soluble 
2 0:1:0:0:0 Completely soluble Slightly soluble 
3 0:0:1:0:0 Practically insoluble Practically insoluble 
4 0:0:0:1:0 Practically insoluble Practically insoluble 
5 0:0:0:0:1 Completely soluble Completely soluble 
6 1:1:0:0:0 Completely soluble Slightly soluble 
7 1:0:1:0:0 Completely soluble Completely soluble 
8 1:0:0:1:0 Completely soluble Slightly soluble 
9 1:0:0:0:1 Completely soluble Slightly soluble 
10 0:1:1:0:0 Completely soluble Completely soluble 
11 0:1:0:1:0 Completely soluble Slightly soluble 
12 0:1:0:0:1 Completely soluble Completely soluble 
13 0:0:1:1:0 Practically insoluble Practically insoluble 
14 0:0:1:0:1 Completely soluble Completely soluble 
15 0:0:0:1:1 Completely soluble Slightly soluble 
16 1:1:1:0:0 Completely soluble Completely soluble 
17 1:1:0:1:0 Completely soluble Completely soluble 
18 1:1:0:0:1 Completely soluble Slightly soluble 
19 0:1:1:1:0 Completely soluble Completely soluble 
20 1:0:1:1:0 Completely soluble Slightly soluble 
21 1:0:1:0:1 Completely soluble Completely soluble 
22 1:0:0:1:1 Completely soluble Slightly soluble 
23 0:1:1:0:1 Completely soluble Completely soluble 
24 0:1:0:1:1 Completely soluble Completely soluble 
25 0:0:1:1:1 Completely soluble Completely soluble 
26 1:1:1:1:0 Completely soluble Completely soluble 
27 0:1:1:1:1 Completely soluble Completely soluble 
28 1:0:1:1:1 Completely soluble Completely soluble 
29 1:1:0:1:1 Completely soluble Slightly soluble 
30 1:1:1:0:1 Completely soluble Completely soluble 
31 1:1:1:1:1 Completely soluble Completely soluble 
 8 
 9 
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Table 5 1 
Solvent effect on size and polydispersity of MPC30-DPA100 nanoparticle systems prepared via nanoprecipitation 2 
(Mean ± SD, n = 3). See Table 2 for solvent formulation details. 3 
 4 
Solvent 
Combination 
Filter 
Diameter 
(ZAve) 
Polydispersity 
Dh
1
 Dh
2
 Dh
3
 
(µm) (nm) (±SD) (Pd) (±SD) (nm) (±SD) (nm) (±SD) (nm) (±SD) 
1 1:0:0:0:0 - 57.1 (0.2) 0.05 (0.02) 61.1 (0.8) - - 
0.45 56.7 (0.3) 0.04 (0.01) 60.4 (0.8) - - 
0.22 56.5 (0.1) 0.05 (0.00) 60.5 (0.4) - - 
2 0:1:0:0:0 - 483.6 (8.4) 0.71 (0.06) 331.6 (115.3) 2180.3 (2588.4) 3459 (2480.9) 
0.45 135.2 (1.9) 0.15 (0.01) 160.1 (3.2) - - 
0.22 133.6 (2.9) 0.10 (0.00) 150.1 (5.0) - - 
3 0:0:1:0:0 - - - - - - 
4 0:0:0:1:0 - - - - - - 
5 0:0:0:0:1 - 1099.0 (351.5) 0.93 (0.09) 233.2 (69.9) 1994.9 (3088.3) - 
0.45 167.6 (0.6) 0.14 (0.02) 193.0 (9.2) 1747.7 (3027.0) - 
0.22 150.2 (7.3) 0.12 (0.03) 169.3 (7.9) 1675 (2901.2) - 
6 1:1:0:0:0 - 177.6 (28.0) 0.51 (0.01) 46.9 (0.5) 346.1 (28.4) 1682.7 (2914.5) 
0.45 85.3 (8.7) 0.43 (0.03) 141.3 (154.8) 195.0 (110.9) 1657 (2870.0) 
0.22 50.6 (4.9) 0.13 (0.07) 55.2 (4.7) 418.7 (725.2) 1286.3 (2228) 
7 1:0:1:0:0 - 415.4 (176.8) 0.68 (0.10) 218.7 (9.4) 1939.1 (2640.2) 2047.4 (3052.1) 
0.45 110.1 (95.6) 0.20 (0.14) 100.2 (87.3) 1791.3 (3102.7) - 
0.22 102.3 (20.8) 0.41 (0.14) 9.9 (6.5) 128.2 (9.1) 3486.3 (3009.1) 
8 1:0:0:1:0 - 55.7 (0.1) 0.05 (0.01) 59.5 (0.5) - - 
0.45 55.3 (0.3) 0.04 (0.00) 58.8 (0.7) - - 
0.22 55.6 (0.2) 0.03 (0.02) 58.9 (0.5) - - 
9 1:0:0:0:1 - 379.6 (8.4) 0.61 (0.03) 292.1 (71.1) 2177.8(2282.2) 3224.3 (2805.0) 
0.45 130.9 (2.8) 0.15 (0.01) 157.5 (3.4) - - 
0.22 133.5 (7.6) 0.12 (0.01) 155.3 (10.7) - - 
10 0:1:1:0:0 - 602.9 (299.1) 0.68 (0.17) 256.0 (61.3) 1919.4 (2217.0) 3540.9 (2979.1) 
0.45 172.96 (36.5) 0.51 (0.11) 44.6 (37.2) 166.8 (32.6) 175.1 (239.9) 
0.22 - - - - - 
11 0:1:0:1:0 - 725.3 (49.6) 0.90 (0.08) 299.3 (31.6) 498.2 (802.5) 1723.5 (2882.3) 
0.45 155.1 (1.0) 0.15 (0.01) 184.5 (5.2) - - 
0.22 125.9 (3.5) 0.13 (0.01) 144.4 (2.9) - - 
12 0:1:0:0:1 - 768.8 (248.7) 0.89 (0.13) 327.9 (151.1) 1737.7 (3009.7) - 
0.45 160.5 (3.1) 0.12 (0.01) 183.1 (5.8) - - 
0.22 145.6 (3.2) 0.11 (0.00) 166.0 (4.2) - - 
13 0:0:1:1:0 - - - - - - 
14 0:0:1:0:1 - - - - - - 
15 0:0:0:1:1 - 770.4 (141.8) 0.88 (0.10) 277.1 (26.0) 1853.3 (3210.1) - 
0.45 174.0 (2.8) 0.11 (0.01) 196.8 (6.9) - - 
0.22 160.9 (1.3) 0.08 (0.01) 176.8 (1.9) - - 
16 1:1:1:0:0 - 244.2 (12.1) 0.24 (0.00) 239.7 (19.2) 3597.3 (3115.4) - 
0.45 157.1 (9.3) 0.15 (0.00) 167.2 (6.6) 1687.3 (2922.5) - 
0.22 132.2 (3.9) 0.13 (0.02) 144.2 (1.2) - - 
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17 1:1:0:1:0 - 692.8 (167.7) 0.88 (0.08) 119.6 (199.1) 137.2 (140.3) 190.3 (38.0) 
0.45 - - - - - 
0.22 - - - - - 
18 1:1:0:0:1 - 412.5 (25.6) 0.65 (0.05) 266.2 (33.3) 1768 (582.3) 4796.3 (247.6) 
0.45 135.1 (2.8) 0.15 (0.01) 11.8 (20.4) 160.3 (3.5) 1494.9 (2556.6) 
0.22 141.4 (6.2) 0.14 (0.00) 12.6 (21.8) 164.7 (5.9) - 
19 0:1:1:1:0 - 719.7 (42.9) 0.89 (0.03) 57.8 (50.1) 102.5 (176.3) 195.8 (37.1) 
0.45 - - - - - 
0.22 - - - - - 
20 1:0:1:1:0 - 209.2 (1.6) 0.49 (0.00) 43.0 (0.8) 370.7 (6.4) - 
0.45 74.5 (7.5) 0.41 (0.04) 128.6 (126.1) 251.2 (172.8) - 
0.22 46.5 (0.2) 0.11 (0.00) 51.4 (0.5) - - 
21 1:0:1:0:1 - 541.2 (167.6) 0.76 (0.10) 20.4 (33.5) 175.5 (37.2) - 
0.45 147.9 (12.9) 0.34 (0.04) 5.2 (6.2) 121.8 (26.5) - 
0.22 96.8 (13.6) 0.46 (0.14) 1.2 (0.2) 16.7 (22.9) 116.3 (7.1) 
22 1:0:01:1 - 405.1 (25.2) 0.64 (0.04) 317.3 (57.5) 1463.0 (2534.0) 3679.8(2358.8) 
0.45 132.4 (1.5) 0.17 (0.01) 157.6 (2.4) 1684.5(2862.7) - 
0.22 140.4 (3.9) 0.14 (0.01) 164.1 (1.9) 1579.2 (2706.2) - 
23 0:1:1:0:1 - 1095.8 (750.2) 0.83 (0.16) 98.4 (25.9) 183.6 (55.3) 379.4 (129.9) 
0.45 143.7 (25.1) 0.37 (0.03) 17.5 (22.7) 118.3 (20.3) 230.0 (374.3) 
0.22 114.6 (4.1) 0.33 (0.05) 1.6 (1.7) 12.4 (10.1) 131.7 (14.1) 
24 0:1:0:1:1 - 860.2 (284.0) 0.91 (0.09) 122.2 (105.9) 306.5 (39.7) 1788.3 (3013.9) 
0.45 155.6 (1.8) 0.14 (0.00) 180.5 (6.2) - - 
0.22 148.3 (1.3) 0.11 (0.02) 165.5 (1.8) - - 
25 0:0:1:1:1 - 651.7 (312.3) 0.81 (0.21) 193.6 (36.5) 668.9 (297.6) 1494.0 (2585.1) 
0.45 - - - - - 
0.22 - - - - - 
26 1-1-1-1-0 - 269.9 (6.3) 0.18 (0.01) 294.7 (4.7) 5015.7 (238.1) - 
0.45 164.8 (4.8) 0.09 (0.02) 179.2 (4.8) - - 
0.22 153.7 (1.4) 0.08 (0.01) 167.2 (3.2) - - 
27 0-1-1-1-1 - 553.6 (68.3) 0.78 (0.04) 184.7 (37.0) 225.6 (105.2) - 
0.45 159.9 (10.1) 0.182 (0.03) 163.4 (9.4) 1723.4 (2984.9) - 
0.22 130.7 (3.3) 0.16 (0.05) 138.4 (7.9) - - 
28 1-0-1-1-1 - 324.9 (30.6) 0.55 (0.07) 179.9 (16.2) 388 (672.0) 1695.7 (2937.0) 
0.45 145.4 (5.2) 0.25 (0.02) 143.8 (10.5) - - 
0.22 126.4 (14.2) 0.23 (0.023) 141.2 (5.1) 1724.7 (2969.9) - 
29 1-1-0-1-1 - 327.5 (17.2) 0.58 (0.04) 299.6 (44.2) 1374.7 (2381.0) 3612.3 (1691.1) 
0.45 133.0 (2.2) 0.15 (0.01) 160.5 (5.6) - - 
0.22 136.0 (1.6) 0.13 (0.00) 11.9 (20.6) 160.3 (1.3) - 
30 1:1:1:0:1 - 472.8 (80.3) 0.72 (0.08) 112.1 (122.7) 158.9 (19.2) - 
0.45 144.7 (3.7) 0.18 (0.02) 149.9 (1.1) - - 
0.22 126.3 (1.2) 0.15 (0.01) 13.0 (22.5) 141.8 (3.5) - 
31 1:1:1:1:1 - 397.1 (105.8) 0.64 (0.16) 42.1 (72.9) 176.5 (25.9) - 
0.45 146.2 (3.1) 0.13 (0.01) 157.3 (3.4) - - 
0.22 133.9 (2.4) 0.12 (0.00) 148.5 (3.4) - - 
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Table 6 1 
Solvent effect on size and polydispersity of MPC100-DPA100 nanoparticle systems prepared via nanoprecipitation 2 
(Mean ± SD, n = 3). See Table 2 for solvent formulation details. 3 
Solvent 
Combination 
Filter 
Diameter 
(ZAve) 
Polydispersity 
Dh
1
 Dh
2
 Dh
3
 
(µm) (nm) (±SD) (Pd) (±SD) (nm) (±SD) (nm) (±SD) (nm) (±SD) 
1 1:0:0:0:0 - 70.3 (0.6) 0.03 (0.01) 73.9 (0.7) - - 
0.45 69.6 (0.5) 0.04 (0.01) 73.4 (0.8) - - 
0.22 69.2 (0.2) 0.03 (0.00) 72.9 (0.4) - - 
2 0:1:0:0:0 - 223.0 (16.7) 0.38 (0.02) 278.5 (33.0) 2047.7 (2391.0) 3190.3 (2768.2) 
0.45 135.8 (6.4) 0.17 (0.01) 161.6 (8.7) 1579.0 (2734.9) - 
0.22 153.7 (5.2) 0.19 (0.01) 23.2 (20.5) 191.4 (4.9) - 
3 0:0:1:0:0 - - - - - - 
4 0:0:0:1:0 - - - - - - 
5 0:0:0:0:1 - 437.1 (47.2) 0.61 (0.03) 504.4 (70.67 1760.3 (3049.0) 3357.4 (2743.2) 
0.45 137.8 (9.4) 0.17 (0.01) 165.1 (12.6) - - 
0.22 172.7 (3.9) 0.16 (0.01) 204.6 (5.5) - - 
6 1:1:0:0:0 - 62.4 (0.7) 0.05 (0.01) 66.6 (0.7) - - 
0.45 61.3 (0.5) 0.05 (0.02) 65.4 (0.3) - - 
0.22 61.5 (0.4) 0.05 (0.01) 65.7 (0.7) - - 
7 1:0:1:0:0 - 559.6 (266.6) 0.65 (0.22) 279.3 (86.4) 3480.7 (2782.1) - 
0.45 131.0 (26.2) 0.52 (0.16) 15.7 (23.2) 190.3 (12.6) 1853.9 (3209.6) 
0.22 195.1 (22.4) 0.28 (0.02) 224.4 (25.4) 1733.1 (2972.2) - 
8 1:0:0:1:0 - 75.8 (0.7) 0.06 (0.00) 81.1 (0.6) - - 
0.45 74.9 (0.9) 0.05 (0.02) 79.8 (0.9) - - 
0.22 75.2 (0.5) 0.04 (0.01) 79.5 (0.5) - - 
9 1:0:0:0:1 - 238.4 (0.6) 0.35 (0.02) 14.6 (25.2) 326.5 (13.8) 4690.0 (454.0) 
0.45 138.7 (6.3) 0.18 (0.01) 21.0 (18.4) 168.9 (9.8) - 
0.22 159.3 (6.5) 0.19 (0.01) 194.6 (10.6) 3264.3 (2828.4) - 
10 0:1:1:0:0 - 309.3 (32.0) 0.45 (0.05) 336.8 (56.5) 574.3 (994.8) 4781.3 (490.2) 
0.45 172.2 (15.8) 0.28 (0.04) 4.9 (6.2) 22.7 (27.2) 197.7 (25.1) 
0.22 184.9 (20.5) 0.23 (0.08) 0.8 (1.3) 209.1 (16.9) 3293.3 (2829.3) 
11 0:1:0:1:0 - 235.0 (10.8) 0.45 (0.02) 293.3 (27.0) 1613.4 (2763.2) 3846.0 (1377.6) 
0.45 131.5 (6.3) 0.13 (0.01) 149.13 (8.50) - - 
0.22 152.5 (5.8) 0.15 (0.01) 12.8 (22.2) 178.6 (7.9) - 
12 0:1:0:0:1 - 523.2 (21.7) 0.69 (0.02) 448.1 (146.3) 1977.6 (2525.2) 3412.7 (2960.7) 
0.45 164.0 (2.0) 0.17 (0.01) 196.4 (4.7) - - 
0.22 187.5 (3.9) 0.18 (0.01) 227.0 (10.3) - - 
13 0:0:1:1:0 - - - - - - 
14 0:0:1:0:1 - 367.1 (156.9) 0.52 (0.17) 255.0 (61.2) 1710.7 (2962.7) 1869.5 (2861.0) 
0.45 195.1 (29.8) 0.42 (0.10) 0.2 (0.4) 274.9 (122.5) 1718.0 (2872.2) 
0.22 119.9 (61.3) 0.61 (0.34) 1.9 (2.6) 27.7 (37.7) 240.6 (36.4) 
15 0:0:0:1:1 - 347.5 (24.3) 0.58 (0.05) 339.6 (19.0) 4800.7 (958.3) - 
0.45 133.9 (4.0) 0.17 (0.01) 23.1 (20.1) 160.9 (5.1) - 
0.22 161.6 (1.1) 0.15 (0.01) 187.5 (1.8) 1628.7 (2820.9) - 
16 1:1:1:0:0 - 461.8 (32.1) 0.50 (0.05) 486.4 (141.7) 2919.4 (2503.6) - 
0.45 174.1 (6.4) 0.15 (0.03) 15.3 (26.5) 205.6 (9.5) - 
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0.22 184.6 (8.8) 0.16 (0.01) 213.4 (13.3) - - 
17 1:1:0:1:0 - 461.5 (93.7) 0.58 (0.15) 334.3 (101.6) 1442.3 (2422.4) - 
0.45 170.2 (13.5) 0.26 (0.04) 3.2 (5.5) 191.8 (20.9) 481.7 (834.3) 
0.22 199.6 (14.3) 0.21 (0.03) 221.3 (10.4) 1572.3 (2723.4) - 
18 1:1:0:0:1 - 245.2 (13.7) 0.41 (0.03) 356.3 (53.8) 4700.7 (335.8) - 
0.45 145.3 (5.3) 0.18 (0.00) 177.47 (7.5) - - 
0.22 163.6 (5.9) 0.20 (0.01) 203.2 (8.5) 2964.3 (2575.8) - 
19 0:1:1:1:0 - 500.7 (32.5) 0.62 (0.03) 58.5 (65.0) 303.4 (372.2) 340.4 (7.1) 
0.45 158.7 (3.8) 0.18 (0.00) 179.6 (2.8) 1673.0 (2897.7) - 
0.22 190.5 (5.2) 0.16 (0.00) 220.7 (1.6) 1604.3 (2778.8) - 
20 1:0:1:1:0 - 65.5 (2.2) 0.06 (0.01) 70.1 (2.9) - - 
0.45 64.8 (1.8) 0.05 (0.02) 69.30 (1.5) - - 
0.22 64.5 (1.5) 0.06 (0.01) 69.3 (2.1) - - 
21 1:0:1:0:1 - 356.6 (12.3) 0.42 (0.03) 27.4 (47.5) 454.4 (76.0) 4599.7 (606.4) 
0.45 176.8 (2.2) 0.12 (0.01) 200.2 (3.9) - - 
0.22 188.0 (7.8) 0.14 (0.01) 217.6 (10.8) - - 
22 1:0:01:1 - 205.8 (12.5) 0.39 (0.01) 10.8 (18.6) 306.1 (15.2) 4258.7 (314.5) 
0.45 131.6 (6.0) 0.16 (0.01) 156.0 (8.8) 3194.7 (2779.0) - 
0.22 147.5 (11.8) 0.19 (0.02) 179.5 (19.7) 3047.3 (2639.1) - 
23 0:1:1:0:1 - 346.3 (27.6) 0.50 (0.02) 93.9 (24.6) 334.8 (23.9) 3522.3 (3051.2) 
0.45 158.5 (5.5) 0.14 (0.01) 177.3 (9.7) 1720.3 (2979.7) - 
0.22 182.1 (5.7) 0.14 (0.01) 211.2 (6.6) - - 
24 0:1:0:1:1 - 507.8 (68.7) 0.75 (0.03) 285.00 (99.5) 2356.37 (2786.3) 3664.3 (3174.0) 
0.45 134.0 (7.5) 0.18 (0.01) 163.3 (11.8) - - 
0.22 156.0 (1.5) 0.19 (0.01) 191.5 (6.7) 1694.3 (2874.9) - 
25 0:0:1:1:1 - 384.7 (133.9) 0.59 (0.16) 252.0 (23.5) 703.2 (1138.0) 2483.0 (2637.1) 
0.45 128.5 (37.5) 0.54 (0.15) 20.6 (28.2) 205.0 (32.2) 3078.1 (2679.9) 
0.22 179.1 (40.8) 0.28 (0.06) 218.5 (49.5) 1798.4 (3113.1) - 
26 1-1-1-1-0 - 521.3 (43.4) 0.69 (0.05) 142.4 (87.8) 377.0 (44.5) 2125.0 (2784.9) 
0.45 165.9 (3.4) 0.13 (0.01) 191.4 (5.2) - - 
0.22 183.7 (11.4) 0.15 (0.02) 213.8 (10.5) - - 
27 0-1-1-1-1 - 545.2 (7.8) 0.69 (0.05) 239.2 (230.0) 352.5 (31.1) 462.6 (692.7) 
0.45 167.4 (1.0) 0.13 (0.00) 190.0 (5.2) 1610.0 (2788.6) - 
0.22 182.9 (9.8) 0.15 (0.02) 16.0 (27.7) 211.3 (10.5) - 
28 1-0-1-1-1 - 506.5 (31.3) 0.65 (0.05) 47.2 (41.4) 312.0 (49.7) 437.6 (419.6) 
0.45 173.0 (3.6) 0.14 (0.00) 199.9 (4.7) - - 
0.22 189.4 (8.7) 0.15 (0.01) 222.4 (12.7) - - 
29 1-1-0-1-1 - 242.5 (6.5) 0.43 (0.03) 13.1 (22.7) 370.7 (43.0) 4293.3 (192.0) 
0.45 136.9 (5.4) 0.16 (0.01) 162.9 (7.7) - - 
0.22 153.03 (9.1) 0.19 (0.03) 187.5 (13.7) 3147.6 (2708.8) - 
30 1:1:1:0:1 - 533.4 (78.5) 0.65 (0.10) 20.9 (36.2) 502.8 (77.9) 1657.4 (2627.3) 
0.45 168.4 (4.5) 0.14 (0.01) 194.3 (7.4) - - 
0.22 188.0 (10.0) 0.15 (0.02) 221.0 (5.8) - - 
31 1:1:1:1:1 - 586.8 (79.6) 0.74 (0.09) 289.4 (98.9) 612.2 (702.6) 1889.0 (2431.2) 
0.45 154.7 (15.0) 0.14 (0.01) 12.9 (22.3) 179.4 (18.5) - 
0.22 188.6 (7.0) 0.15 (0.03) 221.0 (5.6) - - 
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Table 7 1 
AFM measurements and roughness parameters (R) of MPC-DPA copolymer film surface roughness (Mean ± 2 
SD, n = 6). Where Rq = root mean square roughness; Ra = average roughness; and Rz = ten point average 3 
roughness. See Table 2 for solvent formulation details. 4 
# MPC30 - DPA100 Rq (nm) Ra (nm) Rz (nm) 
(a) Solvent 15 231.5 (100.0) 183.6 (86.8) 867.3 (301.1) 
(b) Solvent 24 296.4 (72.0) 242.4 (61.0) 1167.0 (172.7) 
(c) Solvent 26 12.9 (2.3) 10.2 (1.8) 81.9 (6.3) 
 MPC100 - DPA100 Rq (nm) Ra (nm) Rz (nm) 
(d) Solvent 12 80.0 (4.6) 61.1 (3.3) 529.1 (48.0) 
(e) Solvent 16 16.5 (1.7) 13.0 (1.6) 72.7 (5.9) 
(f) Solvent 29 70.7 (16.6) 52.9 (10.0) 284.1 (43.3) 
 5 
Table 8 6 
Solvent effect on size and polydispersity of MPC-DPA nanoparticle systems prepared via film-rehydration 7 
(Mean ± SD, n = 3). See Table 2 for solvent formulation details. 8 
MPC30 - DPA100 
Solvent Combination 
Filter Diameter (ZAve) Polydispersity 
Dh
1
 Dh
2
 Dh
3
 
(µm) (nm) (±SD) (Pd) (±SD) (nm) (±SD) (nm) (±SD) (nm) (±SD) 
15 0:0:0:1:1 - 2257.0 (743.8) 0.70 (0.28) 645.9 (508.9) 2024.0 (3062.5) 2788.4 (2224.6) 
  
0.45 151.4 (3.1) 0.22 (0.04) 169.2 (8.0) 4644.3 (570.5) - 
  
0.22 139.1 (9.1) 0.17 (0.04) 160.3 (8.3) - - 
24 0:1:0:1:1 - 3026.0 (1015.3) 0.48 (0.40) 308.9 (365.0) 1023.4 (493.5) 2587.5 (2243.2) 
  
0.45 149.2 (9.2) 0.20 (0.01) 165.2 (19.4) 1662.0 (2878.6) 3368.7 (1296.7) 
  
0.22 142.8 (7.8) 0.18 (0.00) 163.6 (5.7) 1768.3 (3062.9) - 
26 1:1:1:1:0 - 2871.3 (844.6) 0.59 (0.30) 1688.5 (1250.5) 1763.9 (2514.3) 2130.6 (2509.9) 
  
0.45 144.7 (9.9) 0.20 (0.03) 162.2 (11.5) 4427.0 (797.9) - 
  
0.22 139.3 (2.5) 0.18 (0.03) 160.1 (3.4) 1741.0 (3015.5) 3190.4 (2734.6) 
MPC100 - DPA100 
Solvent Combination 
Filter Diameter (ZAve) Polydispersity 
Dh
1
 Dh
2
 Dh
3
 
(µm) (nm) (±SD) (Pd) (±SD) (nm) (±SD) (nm) (±SD) (nm) (±SD) 
12 0:1:0:0:1 - 831.3 (343.2) 0.79 (0.27) 164.9 (144.3) 920.3 (437.2) 4609.7 (29.0) 
  
0.45 126.7 (16.4) 0.16 (0.04) 150.3 (12.9) 1525.7 (2642.5) - 
  
0.22 153.8 (10.8) 0.14 (0.00) 178.5 (11.1) - - 
16 1:1:1:0:0 - 552.2 (318.7) 0.78 (0.04) 288.1 (265.9) 1723.3 (1981.3) 1851.3 (2441.2) 
  
0.45 118.6 (6.1) 0.10 (0.03) 134.1 (11.4) - - 
  
0.22 136.6 (14.8) 0.13 (0.00) 155.9 (16.6) - - 
29 1:1:0:1:1 - 574.0 (414.4) 0.69 (0.25) 302.8 (147.7) 2291.7 (1608.9) 2557.0 (2327.8) 
  
0.45 124.4 (14.4) 0.12 (0.03) 141.2 (16.2) - - 
  
0.22 148.3 (23.1) 0.12 (0.02) 168.5 (24.5) 1648.3 (2855.0) - 
 9 
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Table 9 1 
MPC-DPA nanoparticle size, polydispersity, zeta potential, and curcumin loading via nanoprecipitation. (Mean ± 2 
SD, n=3). See Table 2 for solvent formulation details. 3 
 4 
Formulation 26 
MPC30-DPA100 
Parameters values after filtration (0.22µm): Mean ± SD, n=3 
 
Diameter  
(nm) 
Poly 
dispersity 
(Pd) 
Zeta 
Potential 
(mV) 
Encapsulation 
Efficiency 
(%) 
Loading 
Capacity 
(%) 
Curcumin 
Loading 
(µg ml
-1
) 
Before loading 
with curcumin 
153.7 (1.4) 0.08 (0.01) -0.34 (1.10) - - - 
After loading with 
Curcumin
a 141.9 (10.4) 0.10 (0.01) -0.83 (0.97) - - - 
After coating with 
TMC polymer
b 136.4 (3.7) 0.12 (0.02) 2.20 (0.09) - - - 
Formulation 12 
MPC100-DPA100 
 
Before loading 
with curcumin 
187.5 (3.9) 0.18 (0.01) -0.50 (0.14) - - - 
After loading with 
Curcumin
c 175.2 (8.1) 0.18 (0.00) -0.55 (0.27) 2.63 (0.30) 0.22 (0.02) 0.92 (0.10) 
After coating with 
TMC polymer
b 162.4 (1.9) 0.16 (0.00) -0.31 (0.49) 2.44 (0.19) 0.20 (0.01) 0.85 (0.06) 
 5 
Table 10 6 
MPC-DPA nanoparticle size, polydispersity, zeta potential, and curcumin loading via film rehydration. (Mean ± 7 
SD, n=3). See Table 2 for solvent formulation details. 8 
 9 
Formulation 26 
MPC30-DPA100 
Parameters values after filtration (0.22µm): Mean ± SD, n=3 
 
Diameter  
(nm) 
Poly 
dispersity 
(Pd) 
Zeta 
Potential 
(mV) 
Encapsulation 
Efficiency (%) 
Loading 
Capacity 
(%) 
Curcumin 
Loading 
(µg ml
-1
) 
Before loading 
with curcumin 
139.3 (2.5) 0.18 (0.03) -0.56 (1.74) - - - 
After loading with 
Curcumin
a 152.5 (30.1) 0.34 (0.15) -1.51 (0.11) - - - 
After coating with 
TMC polymer
b 131.5 (11.6) 0.23 (0.01) 7.99 (3.15) - - - 
Formulation 12 
MPC100-DPA100 
 
Before loading 
with curcumin 
153.8 (10.8) 0.14 (0.00) -0.33 (0.20) - - - 
After loading with 
Curcumin
c 163.7 (3.1) 0.19 (0.01) -0.83 (0.37) 1.96 (1.21) 1.35 (0.83) 6.86 (4.24) 
After coating with 
TMC polymer
b 156.8 (6.3) 0.17 (0.01) 1.04 (0.72) 12.19 (4.90) 8.39 (3.37) 42.57 (17.12) 
 10 
 11 
 12 
 13 
 14 
 15 
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Figures 1 
 2 
Fig. 1. (a) 
1
H NMR spectra of MPC30-DPA100 and MPC100-DPA100 diblock copolymers. (b) GPC elution profiles 3 
of MPC30-DPA100 and MPC100-DPA100 diblock copolymers. 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
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 17 
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 1 
 2 
 3 
Fig. 2. Film rehydration of MPC-DPA copolymers at (a) t = 0, (b) t = 1 day, (c) t = 2 days, (d) t = 4 days, (e) t = 4 
7 days. See Table 2 for solvent formulation details. 5 
 6 
 7 
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 1 
 2 
 3 
Fig. 3. Representative AFM images of MPC-DPA copolymer film surface topography; where Ra = average 4 
roughness, for solvent combinations 15(a), 24(b), 26(c), 12(d), 16(e), and 29(f). See Table 2 for solvent 5 
formulation details. 6 
 7 
 8 
 9 
 10 
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 1 
 2 
Fig. 4. Comparison of preparation method, nanoprecipitation vs film-rehydration, effects on the particle size and 3 
polydispersity of MPC-DPA nanosystems measured using DLS (a) without filtration, (b) after filtration 4 
(0.45µm), and (c) after filtration (0.22µm). (Mean ± SD, n=3). See Table 2 for solvent formulation details. 5 
 6 
 7 
 8 
Fig. 5. Scanning transmission electron microscopy (STEM) images of MPC30-DPA100 (a, b, c) and MPC100-9 
DPA100 (d, e, f) nanoparticles formed via nanoprecipitation from solvent formulations 15 (a), 24 (b), 26 (c), 12 10 
(d), 16 (e), and 29 (f), as per Table 2. Scale bar = 200 nm. See Table 2 for solvent formulation details. 11 
 12 
 13 
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 2 
 3 
Fig. 6. Scanning transmission electron microscopy (STEM) images of MPC30-DPA100 (a, b, c) and MPC100-4 
DPA100 (d, e, f) nanoparticles formed via film rehydration cast from solvent formulations 15 (a), 24 (b), 26 (c), 5 
12 (d), 16 (e), and 29 (f), as per Table 2. Scale bar = 800 nm. See Table 2 for solvent formulation details. 6 
 7 
 8 
Fig. 7. 
1
H NMR spectra of (a) chitosan; chemical shift (ppm) peak assignments: H-Ac = 2.35, H2-D = 3.52, H2-9 
6 = 3.92 – 4.23, and H1-D = 5.21. NMR solvent peak: HOD = 4.73. (b) TMC; chemical shift (ppm) peak 10 
assignments: -NHCH3 = 2.55, -N(CH3)2 = 3.05, and -N
+
(CH3)3 = 3.80. 11 
 12 
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 3 
Fig. 8. Scanning transmission electron microscopy (STEM) images of MPC30-DPA100 (a, b) and MPC100-DPA100 4 
(c, d) nanoparticles formed via nanoprecipitation from solvent formulations 26 (a, b) and 12 (c, d), as per Table 5 
2, and curcumin loaded (a, c) and TMC coated (b, d). Scale bar = 300 nm. See Table 2 for solvent formulation 6 
details. 7 
 8 
 9 
 10 
Fig. 9. Scanning transmission electron microscopy (STEM) images of MPC30-DPA100 (a, b) and MPC100-DPA100 11 
(c, d) nanoparticles formed via film rehydration cast from solvent formulations 26 (a, b) and 12 (c, d), as per 12 
Table 2, and curcumin loaded (a, c) and TMC coated (b, d). Scale bar = 300 nm. See Table 2 for solvent 13 
formulation details. 14 
 15 
 16 
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 2 
Fig. 10. FTIR spectra of (10a) curcumin, (10b) MPC30 -DPA100 and MPC100 -DPA100, (10c) chitosan and TMC, 3 
(10d) curcumin (i), MPC100-DPA100 (ii), MPC30-DPA100 (iii), TMC (iv), physical mix of curcumin and TMC (v), 4 
physical mix of curcumin and MPC100-DPA100 (vi), physical mix of curcumin and MPC30-DPA100 (vii) and (10e) 5 
pure curcumin (i), MPC100-DPA100 (ii), MPC30-DPA100 (iii), solvent mix of curcumin with MPC100-DPA100 from 6 
formulation 12 (iv and v), and solvent mix of curcumin with MPC30-DPA100 from formulation 26 (vi and vii). 7 
The organic solutions for 10e (iv and vi) were those used for nanoprecipitation, and 10e (v and vii) for film 8 
rehydration. 9 
 10 
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